Advances in imaging of inflammatory breast cancer

Cancer

Volumn 116, Issue SUPPL. 11, 2010, Pages 2755-2757

  Yang, Wei Tse ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Inflammatory breast cancer; Magnetic resonance imaging; Mammography; Positron emission tomography computed tomography; Sonography

Indexed keywords

CANCER DIAGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DIGITAL MAMMOGRAPHY; DISTANT METASTASIS; ECHOMAMMOGRAPHY; HUMAN; INFLAMMATORY BREAST CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ARTICLE; BREAST BIOPSY; CANCER STAGING; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; PATIENT MONITORING; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, MAMMARY;

TUMOR MARKER;

EID: 77952716482     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25170     Document Type: Conference Paper

References (16)

1. Dershaw DD, Moore MP, Liberman L, et al. Inflammatory breast carcinoma: mammographic findings. Radiology. 1994; 190:831-834. (Pubitemid 24071055)
2. Gunhan-Bilgen I, Ustun EE, Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. 2002;223:829-838. (Pubitemid 34547604)
3. Kushwaha AC, Whitman GJ, Stelling CB, et al. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol. 2000; 174:535-538.
4. Tardivon AA, Viala J, Corvellec Rudelli A, et al. Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur J Radiol. 1997;24:124-130. (Pubitemid 27165352)
5. Chow CK. Imaging in inflammatory breast carcinoma. Breast Dis. 2005;22:45-54.
6. Yang WT, Le-Petross HT, Macapinlac H, et al. Inflammatory breast cancer-PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat. 2008;109:417-426. (Pubitemid 351692058)
7. Le-Petross HT, Charnsangavej C, Cristofanilli C, et al. Inflammatory Breast Cancer (IBC): Magnetic Resonance Imaging (MRI) Characteristics at 1.5 and 3.0T. In: Proceedings of the Annual Meeting of the Radiological Society of North America, Chicago, Illinois, November 26-30, 2007.
8. Belli P, Costantini M, Romani M, et al. Role of magnetic resonance imaging in inflammatory carcinoma of the breast. Rays. 2002;27:299-305.
9. Eubank WB, Mankoff DA. Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med. 2005;35:84-99. (Pubitemid 40568742)
10. Wahl RL, Siegel BA, Coleman RE, et al. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET study group. J Clin Oncol. 2004;2:277-285. (Pubitemid 41095092)
11. Carkaci S, Macapinlac HA, Cristofanilli M, et al. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med 2009; 50:231-238.
12. Fehr MK, Hornung R, Varga Z, et al. Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy. Breast J. 2004; 10:89-93.
13. Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst. 2005;97:966-975.
14. Danforth DN Jr, Aloj L, Carrasquillo JA, et al. The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer. Breast Cancer Res Treat. 2002;75:135-146.
15. Gil-Rendo A, Zornoza G, Garcia-Velloso MJ, Regueira FM, Beorlegui C, Cervera M. Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer. Br J Surg. 2006;93:707-712. (Pubitemid 43886022)
16. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrence and distant metastasis after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995;87:19-27.